Therefore, we speculated that the reason for negative or weak positive expression of maspin in ovarian cancer was due to the dysfunction of Ets-1 which downregulated maspin expression at transcription level although the expression of Ets-1 was much stronger in ovarian cancer than benign tumors. Here, ETS1 is linked to ovarian cancer.